T. Rowe Price Group

T. Rowe Price Group, Inc. is a publicly owned investment management firm founded in 1937 and headquartered in Baltimore, Maryland. The company offers a diverse range of services, including separate account management, mutual funds, and sub-advisory services, catering to individuals, institutional investors, retirement plans, and financial intermediaries. T. Rowe Price manages investments in both public equity and fixed income markets globally, employing a combination of fundamental and quantitative analysis with a bottom-up investment approach. The firm also engages in socially responsible investing, focusing on environmental, social, and governance issues. In addition to traditional investment strategies, T. Rowe Price participates in late-stage venture capital investments, typically investing between $3 million and $5 million. The company operates numerous offices worldwide, reinforcing its commitment to delivering investment excellence over the long term.

Ziad Bakri

Vice President

Oliver Bell

Associate Head of International Equities, Portfolio Manager, Member of the International Equity Steering Committee and Board Member of T. Rowe Price (Luxembourg) Management

Eiswert C.F.A., CFA, David J.

Vice President and Portfolio Manager

Jennifer St. Germain

Vice President

John Hall

Investment Analyst

Kenneth Moreland

CFO and Treasurer

Anthony Wang

Portfolio Manager - Vice President T. Rowe Price Group

Jeff Zoller

Vice President

315 past transactions

Delfi Diagnostics

Series B in 2022
Delfi Diagnostics, Inc. is a biotechnology company based in Baltimore, Maryland, that focuses on the early detection of cancer through non-invasive blood tests. Founded in 2018, the company utilizes advanced technologies such as artificial intelligence and genome sequencing to identify unique patterns of DNA fragmentation in patients' blood. By leveraging machine learning, Delfi develops innovative testing systems aimed at recognizing cancer-associated cell-free DNA fragments, thereby enabling healthcare professionals to detect cancer at its most treatable stage. This approach facilitates timely and effective treatment options, ultimately aiming to improve patient outcomes and recovery speed.

Flexe

Series D in 2022
FLEXE, Inc. operates a cloud-based warehousing services marketplace that connects organizations needing additional storage and fulfillment capacity with those that have surplus space. Founded in 2013 and based in Seattle, Washington, the company provides a platform that facilitates efficient warehouse sourcing and setup, streamlining material handling operations for clients including retailers, wholesalers, manufacturers, and logistics firms. By addressing inventory overflow and fulfillment challenges, FLEXE enhances the logistics industry and enables businesses to achieve greater structural flexibility in their operations. The company aims to optimize the global delivery of goods and improve access to affordable warehousing solutions, ultimately helping enterprises strengthen their distribution networks and maximize revenue potential.

Senti Bio

Post in 2022
Senti Biosciences is a clinical-stage biotechnology company based in South San Francisco, California, focused on developing innovative gene and cell therapies using its proprietary synthetic biology platform. Founded in 2016, the company aims to address complex diseases through advanced therapeutic solutions. Senti's technology includes engineered allogeneic chimeric antigen receptor natural killer (CAR-NK) cells, which are designed to target and eliminate cancer cells while minimizing damage to healthy tissue. Among its product candidates are SENTI-202, a Logic Gated CAR-NK cell therapy intended for cancer treatment, and SENTI-301A, which targets hepatocellular carcinoma. Senti Biosciences operates as a resident company at Johnson & Johnson Innovation's JLABS in South San Francisco, collaborating with experts in synthetic biology and computation to advance its therapeutic developments.

Convoy

Series E in 2022
Convoy, Inc. operates an online marketplace that provides digital freight network services, facilitating the transportation of goods across the United States. Founded in 2015 and based in Seattle, Washington, the company allows users to book local and regional trucks on demand, accommodating loads ranging from a single pallet to full truckloads. Convoy's platform includes features such as instant quotations, online booking, automated loading suggestions, and real-time shipment tracking, enhancing operational efficiency for shippers. The company aims to address inefficiencies in the trucking industry, which faces significant carbon waste from empty trucks, by leveraging technology and data. Convoy collaborates with major clients, including Fortune 500 companies, to lower logistics costs and meet sustainability goals while improving earnings for drivers.

Sionna

Series B in 2022
Developer of life sciences technology intended to develop highly effective and differentiated treatments for cystic fibrosis. The company is developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with cystic fibrosis, enabling patients with best-in-class efficacy and reach and long-term benefit for people with cystic fibrosis.

Tessera Therapeutics

Series C in 2022
Tessera Therapeutics is an early-stage life sciences company focused on pioneering Gene Writing technology, which allows for the permanent modification of the human genome. This innovative approach enables scientists and clinicians to introduce therapeutic messages into the genome, offering a potential cure for diseases at their source. By building on recent advancements in gene therapy and gene editing, Tessera Therapeutics aims to address significant limitations in these areas, enhancing their applicability and effectiveness. Founded by Flagship Pioneering, the company is positioned to transform genetic medicine and improve patient care through its groundbreaking technology.

Cross River

Series D in 2022
Cross River Bank, based in Fort Lee, New Jersey, offers a range of personal and corporate banking products and services across the United States. These include checking and savings accounts, as well as direct lending options such as commercial real estate loans for various property types in the New York, New Jersey, and Connecticut metro areas. The bank combines traditional banking practices with innovative technology, partnering with fintech companies to create integrated solutions for marketplace lending and payment processing. Cross River emphasizes regulatory compliance and consumer protection, providing secure banking platforms and services that encompass lending, payments, and risk management. Founded in 2008, Cross River operates as a subsidiary of CRB Group, Inc.

SandboxAQ

Series D in 2022
SandboxAQ is an enterprise software company that focuses on artificial intelligence and quantum computing solutions. It provides tools designed to tackle significant challenges in various sectors, including life sciences, finance, and cybersecurity. Notably, SandboxAQ offers post-RSA cybersecurity modules that help organizations enhance their security measures through post-quantum cryptography, aligning with emerging standards in the field. The company’s software is built to facilitate cross-disciplinary collaboration, drawing from fields such as physics, computer science, neuroscience, mathematics, and cryptography. By leveraging its Large Quantitative Models (LQMs), SandboxAQ delivers innovative solutions that address real-world business and computational challenges, thereby enabling clients to advance their technological capabilities.

PrognomIQ

Venture Round in 2022
Developer of medical test products designed to transform the detection and treatment of cancer and other complex diseases. The company's products leverage proteomic data to complement extensive proteomic information with genomic, metabolomic and other health data and discover innovative approaches to early disease detection that translate into transformative test products, enabling medical practitioners to improve diagnostic tests and recurrence monitoring of critical diseases.

RefleXion Medical

Venture Round in 2022
RefleXion Medical Inc. specializes in developing a biologically-guided radiotherapy system aimed at transforming cancer treatment. The company’s innovative technology allows tumors to continuously signal their location during therapy, facilitating the simultaneous treatment of multiple tumors, particularly in cases of metastasis. The RefleXion X1 machine is currently cleared for various forms of radiotherapy, including stereotactic body radiotherapy (SBRT) and intensity-modulated radiotherapy (IMRT). At the core of RefleXion's approach is the integration of positron-emission tomography (PET) imaging, which enables real-time tumor tracking and dose adaptation based on the biological characteristics of the tumors. This advancement in radiotherapy promises to enhance precision in cancer treatment, offering a potential paradigm shift in radiation oncology. RefleXion Medical, incorporated in 2009 and based in Hayward, California, has established strategic collaborations, including partnerships with Telix Pharmaceuticals and HealthMyne.

Rigetti Computing

Post in 2022
Rigetti Computing is a full-stack quantum computing company based in Berkeley, California, with an additional office in Fremont. Founded in 2013, it designs and manufactures quantum integrated circuits and superconducting quantum processors. The company packages and deploys these chips in low-temperature environments and develops accompanying control systems to perform quantum logic operations. Rigetti also offers a cloud services platform, Quantum, which facilitates the integration of its quantum machines into various cloud environments. Additionally, it provides Forest, a programming and execution environment that supports the development of quantum applications. With a focus on near-term applications in computational chemistry and machine learning, Rigetti aims to advance practical quantum computing through its proprietary technology and infrastructure, which enables seamless integration with both public and private cloud systems. The majority of its revenue is generated in the United States.

Saluda Medical

Private Equity Round in 2022
Saluda Medical Pty Ltd. is a medical device company focused on developing innovative solutions for the neuromodulation industry. The firm is known for its investigational device, Evoke, which features a closed-loop spinal cord stimulation system. This technology measures the spinal cord's response to stimulation and adjusts the stimulation parameters in real-time to optimize therapeutic outcomes for patients. Founded in 2010 and headquartered in Artarmon, Australia, with additional offices in Minnesota and the United Kingdom, Saluda Medical aims to provide effective treatment for chronic neuropathic pain. The company's unique approach involves monitoring each patient's neural fingerprint to automatically tailor electrical stimulation, ensuring that therapy is customized to meet individual needs. Saluda Medical's commitment to advancing medical technology is underpinned by a strong foundation of scientific research and a team of experienced professionals.

Cellink

Series D in 2022
CelLink Corporation is an innovative company based in Belmont, California, specializing in the development of flexible conductive backplanes and circuits designed for power electronics. Founded in 2012, the company focuses on applications that include batteries, light-emitting diodes, wire harnessing, and solar cells, among other devices that necessitate effective power transmission. By creating advanced backplane solutions, CelLink aims to enhance efficiency and performance across various electronic applications.

Epirus

Series C in 2022
Epirus, Inc. specializes in the design and development of advanced artificial intelligence-based defense systems aimed at countering drones and asymmetric technologies. Founded in 2018 and located in Hawthorne, California, the company produces high-powered microwave products, including its flagship technology, ELECTROMAGNETIC PULSE, which serves as a drone countermeasure. This innovative solution employs multiple simultaneous beams to neutralize unmanned aircraft systems, while also utilizing software-defined electromagnetic pulse technology to enhance its effectiveness. By integrating computer vision and machine learning, Epirus aims to optimize the detection and tracking of various threats, providing defense organizations with the capability to stun drones or disrupt swarms effectively. The company's products address critical national security challenges in both defense and commercial sectors.

Endeavor BioMedicines

Series B in 2022
Endeavor BioMedicines is a clinical-stage company focused on creating innovative treatments for pulmonary fibrosis, particularly idiopathic pulmonary fibrosis (IPF). The company is developing a small-molecule inhibitor aimed at addressing the underlying causes of this disease. This potential therapy not only seeks to halt the progression of IPF but may also reverse its effects, thereby providing healthcare professionals with precision treatment options for this terminal condition. By targeting the root causes of the disease, Endeavor BioMedicines aims to improve patient outcomes and enhance quality of life for those affected by pulmonary fibrosis.

Eikon Therapeutics

Series B in 2022
Eikon Therapeutics is a biopharmaceutical company focused on developing innovative treatments for chronic and life-threatening diseases. Founded in 2019 and based in Hayward, California, the company utilizes advanced super-resolution microscopy technology to conduct live-cell and single-molecule imaging. This cutting-edge approach allows for real-time, molecular-resolution measurements of protein movement within living cells, enabling the identification of previously intractable drug targets. By directly measuring the interactions between chemical compounds and individual proteins in a cellular environment, Eikon Therapeutics aims to unlock new avenues for drug discovery and address complex health challenges.

SalioGen Therapeutics

Series B in 2022
SalioGen Therapeutics advances in curative genetic therapies using its Exact DNA Integration Technology (EDIT) platform, a mammal-derived genome engineering technology. It is focused on providing durable, safe, and affordable non-viral gene therapies to more patients with inherited diseases. Looking ahead, SalioGen will also explore the EDIT platform’s capabilities to streamline cell therapy, cell engineering, and biologics manufacturing to help an even broader population of patients in need.

DNA Script

Series C in 2022
DNA Script SAS, founded in 2014 and based in Paris, France, specializes in synthetic biology tools and innovative DNA synthesis technology. The company has developed a groundbreaking enzymatic technology that powers the SYNTAX, the world's first benchtop DNA printer. This device allows laboratories to produce synthetic oligonucleotides on-site, significantly enhancing workflow control and expediting access to results. By employing an efficient biochemical process for nucleic acid synthesis, DNA Script enables researchers to rapidly generate essential genomic materials, such as oligonucleotides, which are crucial for genomics and molecular biology applications. Through its advancements, DNA Script aims to facilitate breakthroughs in life sciences and human health.

Pardes Biosciences

Post in 2021
Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus. The Carlsbad, California-based company was established by Uri Lopatin in 2020.

Airtable

Series F in 2021
Airtable is a cloud-based software company founded in 2013 and headquartered in San Francisco, California. It combines features of traditional spreadsheets with the functionality of a database, making it accessible to a wider audience beyond technical users. This platform enables users to create and customize their own workflows, facilitating tasks such as managing editorial calendars and planning events. By providing intuitive tools, Airtable empowers non-coders to build complex workflows and applications, enhancing productivity and collaboration across various projects.

Freenome

Series D in 2021
Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.

Grab

Post in 2021
Grab Holdings Inc., based in Singapore, is a prominent mobile technology platform operating in Southeast Asia. Founded in 2012, the company offers a wide range of services, including ride-sharing through GrabTaxi and GrabCar, and food and grocery delivery. Grab also provides financial services, such as payments, consumer loans, and insurance, catering to both merchants and consumers. Its platform connects drivers and customers, generating revenue primarily through commissions from ride-sharing and food delivery services. Grab operates in eight countries, including Singapore, Indonesia, and Malaysia, where it holds a significant market share. The company has expanded its offerings to include various options for transportation and delivery, as well as a mobile wallet for seamless transactions. Grab continues to face competition from other regional players, such as Foodpanda and Gojek.

Farmer Business Network

Series G in 2021
Farmer Business Network (FBN) is an independent agronomic information network designed to enhance the livelihoods of farmers by making data accessible and useful. Leveraging data science and machine learning, FBN offers its members unbiased insights about their fields, drawing on billions of data points collected from a vast network of farmers. The platform provides valuable resources such as product performance analytics, benchmarking, and predictive insights based on real-world agricultural data. By connecting farmers across the United States, FBN helps them achieve input savings, gain profitable insights, and secure better crop prices, ultimately fostering a collaborative environment that benefits the agricultural community.

Generate:Biomedicines

Series B in 2021
Generate Biomedicines, Inc. specializes in developing a generative biology platform aimed at inventing novel therapeutic proteins, including antibodies, peptides, enzymes, and other related compounds. Utilizing advanced machine learning techniques, the platform analyzes the genetic code that determines protein function, allowing for the creation of new protein sequences optimized for therapeutic applications. This innovative approach enables the company to generate proteins that interact specifically and effectively with targeted therapeutic needs, facilitating the development of new drugs across various protein modalities. Founded in 2018 and located in Cambridge, Massachusetts, Generate Biomedicines was previously known as Generate Biologics, Inc. until its name change in March 2020.

Chroma Medicine

Series A in 2021
Chroma Medicine is a genomic medicine company focused on epigenetic editing to transform the treatment of genetically driven diseases. By leveraging epigenetics, which regulates gene expression naturally, Chroma Medicine aims to develop innovative therapies that provide precise control over gene activity. The company utilizes programmable epigenetic editors that combine DNA binding domains with epigenetic effector domains, allowing for targeted manipulation of genes and chromatin structure. This approach promises to create a new class of therapeutics that offers unparalleled control over gene expression, potentially leading to more effective treatments for a range of genetic disorders.

Socure

Series E in 2021
Socure Inc. specializes in digital identity verification solutions through its Socure ID+ platform, which utilizes predictive analytics, artificial intelligence, and machine learning to authenticate identities in real-time. The platform aggregates data from various online and offline sources, such as emails, phone numbers, and social media, to support compliance with customer identification programs, know your customer guidelines, and anti-money laundering regulations. In addition to the Socure ID+ platform, the company offers tools like Aida, an AI-driven bot for identity validation, Docv for document verification, and Sigma Synthetic Fraud, which addresses synthetic identity fraud. Socure enhances financial inclusion by approving a significant percentage of millennial and thin-file consumers while substantially reducing fraud in online account openings. Founded in 2012 and headquartered in New York, Socure serves a diverse clientele, including software firms, financial institutions, and integration partners, and has established a strategic partnership with ForgeRock.

Arbor Biotechnologies

Series B in 2021
Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.

Nextdoor

Post in 2021
Nextdoor, Inc. is a social networking platform based in San Francisco that facilitates communication among neighbors. Founded in 2010, it enables residents to exchange information, goods, and services, fostering stronger and safer communities. Users can share local news, find services like babysitters, and disseminate safety tips, enhancing neighborhood engagement. The platform also features Help Map, an interactive tool allowing residents to offer assistance to those in need, particularly during emergencies such as the Covid-19 pandemic. With a mission to create a kinder world, Nextdoor connects users to trusted information and resources, promoting real-world connections among neighbors, local businesses, and public services. The company has received funding from notable investors and also maintains a location in London.

Aurora

Post in 2021
Aurora Innovation, Inc. is a technology company focused on developing software and hardware solutions for self-driving vehicles. Founded in 2016 and headquartered in Palo Alto, California, the company also has offices in the Bay Area, Bozeman, Pittsburgh, and Dallas. Aurora's primary product, the Aurora Driver, aims to transform transportation by integrating with automakers, logistics services, mobility services, and fleet management providers. The company's mission is to enhance the movement of people and goods through advanced engineering and machine learning, addressing significant challenges in the transportation sector.

Nuro

Series D in 2021
Nuro, Inc. is a technology company based in Mountain View, California, that specializes in the manufacture of self-driving vehicles designed for local goods transportation. Incorporated in 2016, Nuro focuses on transforming local commerce through autonomous delivery services. The company operates a fleet of electric, fully autonomous vehicles capable of delivering a wide range of products, from food to pharmaceuticals. Nuro's mission is to enhance everyday life by providing quick, affordable, and safe delivery solutions for merchants and their customers.

Nuro

Series D in 2021
Nuro, Inc. is a technology company based in Mountain View, California, that specializes in the manufacture of self-driving vehicles designed for local goods transportation. Incorporated in 2016, Nuro focuses on transforming local commerce through autonomous delivery services. The company operates a fleet of electric, fully autonomous vehicles capable of delivering a wide range of products, from food to pharmaceuticals. Nuro's mission is to enhance everyday life by providing quick, affordable, and safe delivery solutions for merchants and their customers.

Nykaa

Funding Round in 2021
Nykaa is an e-commerce platform based in Mumbai, India, specializing in the sale and distribution of beauty, wellness, and personal care products for both men and women. Founded in 2012 by Falguni Nayar, Nykaa provides a wide range of authentic products sourced directly from brands, ensuring a reliable delivery experience. The platform also offers a wealth of content, including product reviews, beauty tutorials, expert articles, and an e-beauty magazine, enhancing the shopping experience for consumers. Nykaa aims to deliver a content-driven lifestyle retail experience, serving a diverse portfolio of products within the Indian market.

Rad Power Bikes

Series D in 2021
Rad Power Bikes LLC is a Seattle-based manufacturer of electric bicycles, established in 2015. The company specializes in designing and selling feature-rich e-bikes intended for both on and off-road use, focusing on comfort and utility. Rad Power Bikes operates a direct-to-consumer model, enabling customers to purchase their products online at competitive prices. In addition to electric bicycles, the company offers a range of accessories, including storage bags, fenders, racks, and safety products, as well as replacement parts such as batteries and tires. Rad Power Bikes is committed to making sustainable transportation accessible to a wide audience.

Trumid

Venture Round in 2021
Trumid Financial LLC is a financial technology company that specializes in electronic trading solutions for the corporate bond market. Founded in 2014 and based in New York City, Trumid operates the Trumid Market Center, an electronic trading network that connects market professionals to a wide array of liquidity sources. This platform enhances trading efficiency through various protocols and an intuitive design that integrates seamlessly into traders' workflows. Trumid also offers Trumid Bond Stream, which provides real-time TRACE pricing data, and Trumid Labs, which utilizes data science to enhance network management and facilitate bond price lookups. Through its innovative technologies and product offerings, Trumid aims to improve transparency, liquidity, and trade execution in the credit trading space.

Honor

Series E in 2021
Honor Technology, Inc. operates an online platform that connects in-home caregivers with seniors and their families across several states, including California, Texas, New Mexico, Arizona, Ohio, and Michigan. Founded in 2014 and based in San Francisco, the company provides non-medical home care services aimed at helping older adults live safely and comfortably in their own homes. Honor leverages proprietary technology to screen and match caregivers with seniors based on their specific needs. The platform offers features such as the Honor Frame, which informs seniors about their caregivers and arrival times. Additionally, families can monitor caregiver activities and visit durations. By partnering with local agencies through the Honor Care Network, the company enhances caregiver recruiting, training, and scheduling, supporting a reliable and transparent care experience for older adults.

Coalition

Series E in 2021
Coalition, Inc. specializes in providing insurance coverage and risk management tools specifically designed to address cyber risk. Founded in 2017 and based in San Francisco, the company caters to a diverse range of industries, including healthcare, retail, technology, real estate, non-profits, and cryptocurrency. Coalition offers up to $15 million in cyber and technology insurance coverage across the United States and $20 million in Canada. In addition to insurance, Coalition combines proactive cybersecurity measures with its offerings, featuring a cyber risk management platform that delivers automated security alerts, threat intelligence, and expert guidance. This comprehensive approach aims to help businesses effectively manage and mitigate the risks associated with cyber threats.

Ginkgo Bioworks

Post in 2021
Ginkgo Bioworks, founded in 2008 and based in Boston, Massachusetts, specializes in biological engineering by designing, developing, and licensing custom microbes and organisms. The company focuses on discovering and producing a variety of molecules for applications in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. Additionally, Ginkgo Bioworks offers probiotic bacteria aimed at protecting against harmful infections and creates libraries of molecules for various uses. Its market reach includes sectors such as cultured ingredients, carbon mitigation, probiotics, and natural product discovery.

Canva

Venture Round in 2021
Canva, Inc. is a graphic design software provider that offers an online platform enabling users to create presentations, social media graphics, and other visual content. The platform features a user-friendly drag-and-drop design tool, along with a vast library of layouts, images, photo filters, icons, shapes, and fonts. Canva's products include web-based applications and an iPad version, as well as a plug-in called Canva Button that allows third-party websites to integrate design capabilities for their users. Founded in 2012 and headquartered in Sydney, Australia, Canva serves a global audience including photographers, illustrators, and designers, and also provides support services to enhance user experience.

Snyk

Series F in 2021
Snyk Ltd. is a developer-focused cybersecurity company that provides a software-as-a-service platform designed to help organizations identify, fix, and monitor vulnerabilities in open-source dependencies and container images. The platform includes tools such as Snyk Code, which offers static application security testing, and container vulnerability management, which addresses vulnerabilities in Docker images. Snyk enables developers to scan their code for security issues directly within their code editors, providing alerts and remediation guidance based on an internal database of known vulnerabilities. The company also offers features for application security management, licensing compliance, and infrastructure as code security. Founded in 2015 and headquartered in London, Snyk has additional offices in Tel Aviv, Boston, and Ontario, and has established a strategic partnership with Rapid7, Inc.

Checkr

Series E in 2021
Checkr, Inc. is a technology company that specializes in background check services. Founded in 2014 and headquartered in San Francisco, California, Checkr offers a range of screening services, including criminal record checks, driving checks, and identity verification, all delivered through an advanced platform that can provide faster turnaround times compared to traditional background check providers. The company utilizes artificial intelligence and machine learning to enhance the hiring process, ensuring compliance and improving the applicant experience. Checkr serves various industries, including financial services, healthcare, retail, and technology, by providing tools that help organizations navigate the complexities of workforce dynamics while promoting transparency and fairness in hiring. Additionally, Checkr offers security solutions, continuous monitoring, and a unified identity verification service, Checkr Connect IDV, which integrates identity verification with background checks.

SomaLogic

Post in 2021
SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.

Databricks

Series H in 2021
Databricks Inc. offers a unified data analytics cloud platform focused on simplifying data engineering and collaborative data science. The company's platform facilitates data integration, real-time experimentation, and the deployment of production applications for developers and data scientists. Key products include Databricks, a cloud-based data processing solution, Databricks Delta for unified data management, MLflow for managing the machine learning lifecycle, and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including advertising, healthcare, financial services, and manufacturing. The company, founded in 2013 and headquartered in San Francisco with additional offices in London, Amsterdam, and Bengaluru, has formed strategic partnerships with various technology firms. Additionally, Databricks Ventures invests in companies that align with its vision for data, analytics, and artificial intelligence, particularly through initiatives like the Lakehouse Fund, which supports the development of the lakehouse architecture.

Laronde

Series B in 2021
Laronde is focused on developing innovative therapeutics using its proprietary Endless RNA™ (eRNA) platform, which allows for the modulation of human biology through uniquely engineered RNA. This technology enables the expression of diverse proteins within the body while being persistent, non-immunogenic, and suitable for repeat dosing. Additionally, it provides flexibility in formulation and delivery, making it a promising foundation for new medicines. Founded in 2017 by Flagship Labs, Laronde is rapidly scaling its operations to support the simultaneous development of various programs targeting multiple disease areas, aiming to create more predictable and impactful treatments in the healthcare sector.

Seismic

Series G in 2021
Seismic’s leading sales enableSeismic is the leading global sales and marketing enablement solution, improving close rates, and delivering larger deals for sales while increasing marketing’s impact on the bottom line. Large enterprises use Seismic to increase sales productivity through the automatic distribution of relevant information and personalized content to reps for any buyer interaction. Powerful content controls and visibility into usage ensures brand integrity and reduces risk. Seismic’s machine learning and analytics capabilities continuously improve the entire enablement process for large enterprises, increasing the ROI of sales content and tying it directly to revenue. Headquartered in San Diego and with more than 300 employees across the globe, Seismic is privately held by its executive team and investment firms General Atlantic, JMI Equity, and Jackson Square Ventures.

Gusto

Series E in 2021
Gusto is a company that provides a cloud-based platform designed for small and medium-sized businesses to manage payroll, benefits, and human resources. Founded in 2011 and headquartered in San Francisco, with an additional office in Denver, Gusto offers an array of services including payroll processing, health benefits, workers' compensation, and time tracking. The platform allows employers and employees to access payroll information from various devices, enabling features such as browsing pay stubs, reviewing tax forms, and verifying personal details. Gusto caters to a diverse clientele, including startups, coffee shops, medical practices, creative agencies, and law firms, aiming to simplify the administrative tasks associated with employee management.

CCC Drive

Post in 2021
CCC Drive, based in Glen Allen, Virginia, provides a versatile technology platform for insurance telematics, known as DriveFactor. This platform allows for the integration of data from various sources and facilitates sharing with business partners. CCC Drive enables clients to manage the entire claims process, including intake, evaluation, settlement, and optimization. The company, originally founded in 2010 as DriveFactor Inc., became a subsidiary of CCC Information Services Inc. in 2015. CCC Information Services focuses on enhancing claims management through integrated solutions, offering advanced collision repair and insurance estimating software, analytical tools, and data services. Their technology improves efficiency across the claims management supply chain, fostering communication among a network of approximately 21,000 auto body collision repair facilities and 350 insurance companies.

Redwood Materials

Series C in 2021
Redwood Materials, Inc. is a recycling and materials processing company based in Carson City, Nevada, founded in 2017. The company specializes in developing sustainable methods for recycling various metals and materials, particularly from batteries and electronics, to support circular supply chains. Its focus includes lithium, nickel, copper, gold, silver, cobalt, and other critical elements used in electric vehicles, renewable energy storage, and consumer electronics. By providing environmentally sound recycling solutions, Redwood Materials aims to address the increasing demand for battery end-of-life management as the number of electric vehicles rises globally. The company's innovative technology not only recycles waste but also generates essential raw materials, enabling manufacturers to create sustainable products and significantly contributing to the transition towards a circular economy.

Ring Therapeutics

Series B in 2021
Ring Therapeutics, Inc. is a biotechnology company that specializes in developing gene therapies through its innovative viral vector platform, Anellovector. This platform leverages the human commensal virome to create redosable and targetable DNA therapies, addressing key limitations of existing gene and DNA treatments, such as restricted access to diverse tissues and challenges with tolerability and genomic integration. Founded in 2017 and based in Cambridge, Massachusetts, Ring Therapeutics aims to expand the scope of gene therapy beyond traditional gene replacement, enabling a broader range of applications across various medical fields, including genetic disorders, ophthalmology, oncology, and metabolic diseases. By focusing on cellular and tissue specificity, the company aspires to unlock new therapeutic possibilities for previously inaccessible conditions.

Rivian

Private Equity Round in 2021
Rivian Automotive, LLC is an automotive technology company that specializes in the development and manufacturing of electric adventure vehicles. Founded in 2009 by Robert J. Scaringe, the company is headquartered in Plymouth, Michigan, with additional facilities across multiple locations, including California, Illinois, the United Kingdom, and Canada. Rivian's primary offerings include the R1T, a five-passenger electric pickup truck, and the R1S, a seven-passenger electric sport utility vehicle. The company aims to advance sustainable mobility by creating innovative electric vehicles that redefine traditional automotive economics while providing a comfortable and eco-friendly driving experience.

GeneDx

Post in 2021
Sema4 is a patient-centered predictive health company dedicated to advancing the diagnosis, treatment, and prevention of disease. With their innovative Sema4 Health Intelligence Platform, they’re using advanced network analysis to build better models of human health and deliver personalized insights for patients.

Atama plus

Series B in 2021
Atama plus Inc., founded in 2017 and headquartered in Tokyo, Japan, is an Edtech startup that leverages artificial intelligence to enhance educational experiences for middle and high school students. The company focuses on providing personalized learning solutions aimed at helping students develop essential academic skills efficiently. By analyzing a range of data, including learning history and individual proficiency levels, Atama plus offers fully customized educational pathways tailored to each student’s unique needs and challenges. This innovative approach combines the strengths of AI with human insight, aspiring to revolutionize traditional education methods and improve overall learning outcomes.

Rappi

Series F in 2021
Rappi S.A.S. is an online delivery platform that offers a variety of services, including food, grocery, and clothing delivery. Founded in 2015 and headquartered in Bogotá, Colombia, the company operates in several Latin American countries, including Argentina, Brazil, Chile, Mexico, Peru, and Uruguay. Rappi connects consumers with independent contractors who fulfill their orders, making it a versatile choice for those seeking convenience in their shopping needs. The platform has gained popularity for its ability to deliver a wide range of products quickly and efficiently.

Wheels Up

Post in 2021
Wheels Up is a membership-based private aviation company that focuses on reducing the upfront cost to fly privately, providing flexibility, service, and safety. Its mobile app enables members to book flights, manage their accounts, and participate in ride-share opportunities. Its members also have given access to the Wheels Down program. The company was founded in 2013 and headquartered in New York, United States.

Prime Medicine

Series B in 2021
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

ServiceTitan

Series G in 2021
ServiceTitan, Inc. offers a cloud-based business management software designed for field service companies, aiming to streamline operations and enhance customer service. The platform provides a comprehensive suite of tools for dispatching, scheduling, call booking, marketing, reporting, financing, and customer experience. It caters to various industries, including HVAC, plumbing, electrical services, and more, across the United States and Canada. Founded in 2013 by Ara Mahdessian and Vahe Kuzoyan, ServiceTitan was developed in response to a lack of effective software solutions in the home services sector, inspired by the founders' family backgrounds in contracting and plumbing. The company is headquartered in Glendale, California, with additional offices in Atlanta and Armenia.

PROCEPT BioRobotics

Series G in 2021
PROCEPT BioRobotics is a surgical robotics company focused on enhancing patient care through innovative solutions in urology. Founded in 2009 and based in Redwood Shores, California, the company has developed the AquaBeam Robotic System, an autonomous robot designed for the removal of prostate tissue. This system supports Aquablation therapy, a minimally invasive treatment for lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH). By leveraging advanced robotics, PROCEPT BioRobotics aims to improve surgical outcomes and patient experiences in the treatment of urological conditions.

Element Biosciences

Series C in 2021
Element Biosciences, Inc. develops genetic analysis tools for the research and diagnostic markets. The company provides a disruptive DNA sequencing technology and a sequencing platform, such as surface chemistry, sequencing chemistry, detection, and data analysis. The company was incorporated in 2017 and is based in San Diego, California.

Payoneer

Post in 2021
Payoneer Inc. operates a cross-border payments platform designed to facilitate global commerce by connecting businesses, professionals, countries, and currencies. Founded in 2005 and headquartered in New York, the company offers products such as the Global Payment Service, which provides users with local receiving accounts in the United States, European Union, and Japan, allowing for direct local bank transfers. Additionally, Payoneer enables users to receive payments from various integrated partners, including those in freelance, e-commerce, and online advertising sectors. The company also provides mass payout services that assist Indian companies in transferring funds internationally. Serving millions of users across over 200 countries, Payoneer is a trusted partner for numerous prominent corporations, making cross-border payments as straightforward as local transactions.

GOAT

Series F in 2021
GOAT is a global marketplace specializing in authentic sneakers, apparel, and accessories from contemporary luxury brands. Founded in 2015 by Daishin Sugano and Eddy Lu in Culver City, California, the platform provides users with access to exclusive drops, the ability to make offers on desired items, and a selection that spans from iconic styles of the past to future classics. GOAT operates both online and through thirteen physical locations across the United States, Asia, and Europe, including distribution and authentication centers that serve 170 international markets. The platform features over 350 brands and has built a community of over 20 million members across 164 countries. By leveraging innovative technology, GOAT has transformed sneaker commerce, ensuring the authenticity of products while bridging the gap between primary and resale markets. Strategic backing from investors such as Foot Locker and prominent venture capital firms underscores its significant presence in the fashion and sneaker industries.

Waymo

Private Equity Round in 2021
Waymo stands for a new way forward in mobility. it is a self-driving technology company with a mission to make it safe and easy for people and things to move around. Waymo improves transportation by building software and sensor technology developed in Google’s labs since 2009. In October 2015, they achieved the world’s first fully self-driving trip on public roads, in a car without a steering wheel or pedals. They refine Waymo technology through one billion miles of simulation testing each year, and the cars have self-driven over two million miles on public roads across four U.S. cities. It was founded in 2009 and is located in Mountain View, California.

Jetti Resources

Series C in 2021
Jetti Resources is a Canadian company founded in 2014, headquartered in Vancouver, specializing in the development of hydrometallurgical technology for metal extraction from mineral ores. The company focuses on extracting copper from low-grade primary sulfides, particularly chalcopyrite, the most abundant copper mineral ore. Jetti's proprietary catalytic technology effectively addresses the challenges associated with recovering vast amounts of trapped resources, significantly enhancing copper yields while being cost-effective and environmentally responsible. In addition to copper, the technology can also be applied to the extraction of zinc and nickel from sulfide ores, contributing to more efficient mineral processing practices.

Celonis

Series D in 2021
Celonis is a company that specializes in execution management, leveraging its advanced process mining technology to help businesses optimize their operations. Its Execution Management System (EMS) offers a comprehensive suite of tools and applications designed for analyzing and enhancing various business processes, including production, human resources, and logistics. By providing insights into process transparency and efficiency, Celonis enables organizations to improve their execution capacity. The company serves a wide range of industries and boasts a diverse client base that includes prominent names like AstraZeneca, Coca-Cola, and Siemens. Headquartered in Munich, Germany, and New York City, USA, Celonis has a global presence with 15 offices worldwide.

Celonis

Series D in 2021
Celonis is a company that specializes in execution management, leveraging its advanced process mining technology to help businesses optimize their operations. Its Execution Management System (EMS) offers a comprehensive suite of tools and applications designed for analyzing and enhancing various business processes, including production, human resources, and logistics. By providing insights into process transparency and efficiency, Celonis enables organizations to improve their execution capacity. The company serves a wide range of industries and boasts a diverse client base that includes prominent names like AstraZeneca, Coca-Cola, and Siemens. Headquartered in Munich, Germany, and New York City, USA, Celonis has a global presence with 15 offices worldwide.

Clear Labs

Series C in 2021
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company offers a comprehensive food analytics platform that utilizes next-generation sequencing to analyze the molecular contents of foods and ingredients. This platform provides food manufacturers, suppliers, and retailers with crucial transparency across supply chains, testing products for authenticity, contaminants, allergens, and various other factors such as GMOs, heavy metals, and nutrition. Clear Labs also focuses on simplifying complex diagnostics for clinical and applied markets, combining DNA sequencing, robotics, and cloud-based analytics to improve accuracy and accelerate outcomes. By delivering insights into food safety and quality, Clear Labs aims to enhance understanding and management of potential health risks associated with food products and emerging pathogens.

Caris Life Sciences

Private Equity Round in 2021
Caris Life Sciences is a biotechnology company based in Irving, Texas, specializing in precision medicine and cancer treatment. Founded in 1996, the company develops and commercializes advanced diagnostic technologies, including anatomic pathology and molecular profiling, to enhance the understanding of cancer biology. Its services encompass comprehensive molecular analyses of patient samples, integrating genomic, transcriptomic, and proteomic profiling through the Caris Molecular Intelligence platform. This platform aids physicians and cancer patients in making informed and personalized treatment decisions by revealing the molecular blueprint of complex diseases. Caris Life Sciences serves a global customer base through distributors in regions including the United States, Europe, and Australia, and maintains a strategic collaboration with Debiopharm International SA. The company is committed to improving patient outcomes through innovative scientific advancements and a focus on quality care.

Capsule

Series D in 2021
Capsule Corporation is an innovative online pharmacy established in 2015 and headquartered in New York, New York. It aims to transform the pharmacy industry by providing a streamlined and personalized experience for patients, healthcare providers, insurers, and manufacturers. Capsule's platform facilitates the online retail of pharmaceutical products through a user-friendly application that focuses on creating customized outcomes for its users. The company emphasizes the importance of human connection in healthcare, recognizing that behind the complexities of the system, there are individuals in need of care and support. Capsule has successfully raised significant funding from prominent investors, enabling it to further its mission of enhancing the pharmaceutical experience through technology and dedicated service.

Cava

Series F in 2021
Cava Group, Inc. operates a chain of Greek and Mediterranean restaurants known for their modern mezze offerings, including salads, dips, spreads, and dressings. Founded in 2006 and headquartered in Washington, D.C., the company is recognized as a leader in the Mediterranean fast-casual dining sector, focusing on healthful and flavorful food options. Cava produces its dips, spreads, and sauces daily in small batches at its facility in Laurel, Maryland, ensuring they are free of additives and preservatives. In addition to its restaurant operations, Cava's products are also sold in grocery stores. The company has established strategic partnerships with organizations such as the Garden School Foundation and Sow Much Good, reflecting its commitment to community engagement and healthy eating. Cava Group generates most of its revenue from its primary segment, CAVA, while also operating Zoes Kitchen as a separate segment.

Clio

Series E in 2021
Themis Solutions Inc. develops legal practice management and client intake software solutions for law firms. The company’s platforms are used for billing, case management, contact management, document management, calendaring, online payments, and time and expense tracking. The company was founded in 2007 and is based in Burnaby, Canada with additional offices in Toronto, Calgary, Canada; Santa Monica, California; and Dublin, Ireland.

LUMICKS

Series D in 2021
LUMICKS B.V. is a company that specializes in developing advanced equipment for dynamic single-molecule and cell avidity analysis, facilitating research in biology and cancer at the molecular and cellular levels. Founded in 2014 and headquartered in Amsterdam, with an additional office in Cambridge, Massachusetts, LUMICKS offers innovative technologies such as correlative optical tweezers-fluorescence microscopy systems and the C-Trap, which integrates optical tweezers with advanced imaging techniques. The company’s Acoustic Force Spectroscopy (AFS) enables the study of mechanical properties in biological systems, while its u-Flux microfluidics system allows for single-molecule experiments in controlled laminar flow environments. By enabling live measurements and imaging of molecular interactions, LUMICKS provides valuable insights into the fundamental causes of diseases, including cancer, and supports drug optimization efforts.

Theseus Pharmaceuticals

Series B in 2021
Theseus Pharmaceuticals is a Technology based company.

Epic Games

Venture Round in 2021
Epic Games, Inc. is an American video game and software company based in Cary, North Carolina. Founded in 1991, the company develops and creates games for various platforms, including PCs, consoles, mobile devices, artificial reality, and virtual reality. In addition to its own game development, Epic Games offers its game engine technology to other developers, enabling them to create high-fidelity, interactive experiences. The company also operates a game store that supports independent developers in producing quality games and 3D content. Originally known as Epic MegaGames, Inc., the company rebranded to Epic Games, Inc. in March 1999.

Canva

Venture Round in 2021
Canva, Inc. is a graphic design software provider that offers an online platform enabling users to create presentations, social media graphics, and other visual content. The platform features a user-friendly drag-and-drop design tool, along with a vast library of layouts, images, photo filters, icons, shapes, and fonts. Canva's products include web-based applications and an iPad version, as well as a plug-in called Canva Button that allows third-party websites to integrate design capabilities for their users. Founded in 2012 and headquartered in Sydney, Australia, Canva serves a global audience including photographers, illustrators, and designers, and also provides support services to enhance user experience.

Scribe Therapeutics

Series B in 2021
Scribe Therapeutics Inc. is a biotechnology company focused on developing innovative therapeutics using CRISPR technology to address genetic disorders. Founded in 2017 and based in Berkeley, California, Scribe specializes in engineering CRISPR enzymes known as X-Editing (XE) molecules, which enhance the efficacy, specificity, and deliverability of genome editing compared to existing methods. The company's proprietary platform enables the creation of custom-engineered enzymes and delivery systems, facilitating precision targeting within the genome. Scribe Therapeutics aims to establish CRISPR-based therapies as a standard in clinical care, expanding access to transformative treatments for a wide range of conditions, including immuno-oncology and degenerative disorders. Through its commitment to overcoming the limitations of current genome editing technologies, Scribe Therapeutics is poised to make substantial contributions to human therapeutics.

Gyroscope

Series C in 2021
Gyroscope is an ophthalmology company developing gene therapies for the treatment of eye diseases linked to an unbalanced complement system. Gyroscope was founded to explore the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD) and gene therapy as a mode of treatment delivery.

ABL Space Systems

Series B in 2021
ABL Space Systems is a company focused on designing and manufacturing low-cost rockets for the small satellite market. Founded in 2017 by former SpaceX engineers, the company is headquartered in El Segundo, California, where it operates facilities covering 30,000 square feet dedicated to research, development, and production. ABL's primary launch vehicle, the RS1, is designed to support various configurations for deploying small satellites, including multi-manifest and dedicated launches. The company's innovative approach features a simplified tank architecture and advanced propellant management systems, which aim to enhance the efficiency and routine nature of orbital launches. As a privately-owned entity, ABL is backed by a group of prominent private equity investors.

SecurityScorecard

Series E in 2021
SecurityScorecard, Inc. is a cybersecurity ratings and continuous monitoring platform that evaluates the cybersecurity strength of businesses and third-party vendors. Founded in 2013, the company has developed a patented technology that provides instant risk ratings for over a million companies, helping organizations manage their cybersecurity risks more effectively. Its offerings include ThreatMarket, a cloud-based vulnerability search engine that assesses security posture across various risk categories, and Score Planner, which allows companies to explore remediation strategies. Additionally, SecurityScorecard provides tools for vendor risk management, board reporting, and cyber insurance underwriting through its Scorecard Event Log and Atlas platform for questionnaire management. The company serves a global clientele, including Fortune 1000 organizations, and collaborates with value-added resellers and service partners to deliver its solutions. Based in New York, SecurityScorecard aims to enhance organizational resilience by facilitating the identification and mitigation of cybersecurity risks.

Squarespace

Venture Round in 2021
Squarespace is the all-in-one platform for websites, domains, online stores, marketing tools and scheduling, which entrepreneurs, creatives, and professionals use to build a beautiful presence and maintain their brands online.

Rapid Micro Biosystems

Private Equity Round in 2021
Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration. The company was formerly known as Genomic Profiling Systems and changed its name to Rapid Micro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.

insitro

Series C in 2021
Insitro, Inc. is a data-driven drug discovery and development company based in South San Francisco, California, founded in 2018. The company utilizes machine learning and high-throughput biology to transform the traditional processes of drug discovery and delivery. By generating extensive functional genomic datasets and aligning them with patient data through innovative machine learning techniques, Insitro builds predictive models that aim to address critical challenges in pharmaceutical research and development. These models facilitate accelerated target selection and the design of effective therapeutics, ultimately enhancing the efficiency of drug development and informing clinical strategies. The focus of Insitro's work includes the treatment of nonalcoholic steatohepatitis (NASH), showcasing its commitment to addressing significant health issues through advanced technology.

Instacart

Venture Round in 2021
Instacart is a grocery delivery service that enables customers to receive groceries and home essentials at their doorstep, often within an hour. Founded in 2012 and headquartered in San Francisco, Instacart offers a wide selection of over 500,000 items from various local grocery stores, including well-known retailers such as Safeway, Whole Foods, and Costco. Customers can conveniently combine products from multiple stores into a single order, making the shopping experience more efficient. The company connects customers with individual shoppers who fulfill their orders, allowing for a personalized service. Instacart has garnered significant funding from various prominent investment firms, supporting its growth and expansion in the competitive grocery delivery market.

Tenaya Therapeutics

Series C in 2021
Tenaya Therapeutics is a biotechnology company based in South San Francisco, California, focused on developing innovative therapies for heart disease, particularly heart failure. Established in 2016, the company employs three main platforms to address the underlying causes of heart disease: a cellular regeneration platform that reprograms cardiac fibroblasts into cardiomyocytes using proprietary transcription factors, a gene therapy platform for targeted delivery of therapeutic payloads, and a precision medicine approach tailored to individual patients. Through these platforms, Tenaya Therapeutics aims to enable the regeneration of heart tissue and tackle various forms of cardiomyopathies, leveraging advanced research in cardiac development and regeneration.

Vividion Therapeutics

Series C in 2021
Vividion Therapeutics, Inc. is a biotechnology company based in San Diego, California, focused on developing therapeutics to address significant unmet medical needs. The company utilizes a novel platform for proteome-wide small molecule drug discovery, which combines proteomic techniques and synthetic chemistry to enhance drug selectivity and broaden the range of druggable proteins. Originating from research at The Scripps Research Institute, Vividion's technology enables the creation of detailed drug interaction maps, facilitating simultaneous target engagement and comprehensive selectivity profiling. By advancing its innovative synthetic and proteomic chemistry approaches, Vividion aims to deliver transformative treatments for patients with serious illnesses.

Centessa Pharmaceuticals

Series A in 2021
Centessa Pharmaceuticals is a clinical-stage biopharmaceutical company focused on transforming the drug development process through an asset-centric research and development model. The company advances a diverse portfolio of validated programs, each managed by a dedicated subsidiary and backed by a centralized infrastructure and experienced management team. Among its pipeline assets are SerpinPC, targeting Hemophilia A and B, LB101 for solid tumors, ORX750 for narcolepsy type 1 and other sleep disorders, and MGX292 for pulmonary arterial hypertension. Additionally, Centessa is developing an undisclosed asset for solid tumors.
Day One Biopharmaceuticals is a clinical-stage biotechnology company focused on developing targeted therapies for genetically defined cancers in patients of all ages, with an initial emphasis on pediatric patients. Founded in 2018 and headquartered in South San Francisco, California, the company aims to address the critical needs of children and adults diagnosed with cancer by creating innovative treatments derived from the biology of childhood cancer. Day One Biopharmaceuticals prioritizes programs that can be swiftly brought to market, thereby providing timely options for families facing cancer diagnoses. Its lead product candidate, DAY101, is an oral, brain-penetrant pan-RAF kinase inhibitor designed to target specific cancer types. The company seeks to license and acquire promising therapeutic products from research institutions and other biotechnology and pharmaceutical companies, striving to enhance the treatment landscape for underserved populations.

Rad Power Bikes

Venture Round in 2021
Rad Power Bikes LLC is a Seattle-based manufacturer of electric bicycles, established in 2015. The company specializes in designing and selling feature-rich e-bikes intended for both on and off-road use, focusing on comfort and utility. Rad Power Bikes operates a direct-to-consumer model, enabling customers to purchase their products online at competitive prices. In addition to electric bicycles, the company offers a range of accessories, including storage bags, fenders, racks, and safety products, as well as replacement parts such as batteries and tires. Rad Power Bikes is committed to making sustainable transportation accessible to a wide audience.

Stash

Series G in 2021
Stash Financial Inc., based in New York, operates a digital investing and banking platform designed to make personal finance accessible for everyday Americans. Established in 2015, Stash offers a mobile application that consolidates banking, investing, and financial advice, facilitating budgeting, saving, and retirement planning. The platform allows users to create personal investment accounts, retirement accounts, and custodial accounts for minors, with the option to purchase fractional shares of stocks, bonds, and funds without additional trading commissions. By simplifying the investment process, Stash has enabled over 5 million individuals to work towards their financial goals and enhance their wealth-building potential.

Databricks

Series G in 2021
Databricks Inc. offers a unified data analytics cloud platform focused on simplifying data engineering and collaborative data science. The company's platform facilitates data integration, real-time experimentation, and the deployment of production applications for developers and data scientists. Key products include Databricks, a cloud-based data processing solution, Databricks Delta for unified data management, MLflow for managing the machine learning lifecycle, and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including advertising, healthcare, financial services, and manufacturing. The company, founded in 2013 and headquartered in San Francisco with additional offices in London, Amsterdam, and Bengaluru, has formed strategic partnerships with various technology firms. Additionally, Databricks Ventures invests in companies that align with its vision for data, analytics, and artificial intelligence, particularly through initiatives like the Lakehouse Fund, which supports the development of the lakehouse architecture.

UiPath

Series F in 2021
UiPath develops and provides robotic process automation software designed to enhance operational efficiency across various industries. The company offers a comprehensive platform for hyper automation, enabling enterprises to discover, build, manage, and optimize automation opportunities. Key products include UiPath Studio, which allows users to design automation processes with an intuitive graphical interface, and UiPath Orchestrator, which manages automation workflows and deployments. UiPath’s solutions cater to a variety of sectors, including finance, healthcare, insurance, and telecommunications, facilitating the automation of tasks such as accounts payable, claims processing, and customer service. Founded in 2005 and headquartered in New York, UiPath also has offices in several major cities worldwide, including London, Bucharest, and Tokyo. The company focuses on integrating advanced technologies, such as artificial intelligence, to streamline processes and improve business outcomes.

Design Therapeutics

Series B in 2021
Design Therapeutics, Inc. is a clinical-stage biotechnology company based in Solana Beach, California, focused on developing innovative therapies for degenerative disorders resulting from nucleotide repeat expansions. Founded in 2017, the company is advancing its lead program aimed at treating Friedreich's ataxia, while also exploring treatment options for other conditions such as Fragile X syndrome and myotonic dystrophy. Design Therapeutics is known for its GeneTACTM molecules, a new class of small-molecule gene-targeted therapies designed to address the underlying causes of diseases linked to inherited nucleotide repeat expansion mutations. The company's ongoing research efforts seek to develop disease-modifying treatments for serious conditions driven by these genetic factors.

Sila

Series F in 2021
Sila Nanotechnologies Inc. specializes in developing advanced materials for batteries that enhance energy density. The company serves various sectors, including automotive, consumer electronics, electric utilities, and aerospace, by providing innovative battery materials chemistry. Founded in 2011 and based in Alameda, California, Sila collaborates closely with leading original equipment manufacturers (OEMs) to support their product development timelines and partners with battery manufacturers to facilitate commercial cell production.

Vimeo

Private Equity Round in 2021
Vimeo is a prominent video software platform that provides tools for creating, sharing, and discovering videos. It caters to a diverse user base of over 200 million individuals, including creatives, entrepreneurs, and large organizations. The platform facilitates video production, collaboration, and communication, making it a valuable resource for professionals and teams seeking to leverage video content effectively. With its comprehensive features, Vimeo supports users in unlocking the potential of video for various applications.

Kardium

Private Equity Round in 2021
Kardium Inc. is a medical solutions company based in Burnaby, Canada, specializing in the diagnosis and treatment of atrial fibrillation (AF). Founded in 2007, the company has developed the Globe Mapping and Ablation System, which streamlines AF treatment by integrating single-shot pulmonary vein isolation, high-definition mapping, and atrial ablation into a single catheter. This advanced system aids medical practitioners in diagnosing and treating cardiovascular diseases by providing detailed electrophysiological mapping and the ability to ablate cardiac tissue using radio-frequency energy. Kardium's team comprises experts in medicine, engineering, and research, ensuring a robust foundation for innovation in medical device technology.

Rivian

Private Equity Round in 2021
Rivian Automotive, LLC is an automotive technology company that specializes in the development and manufacturing of electric adventure vehicles. Founded in 2009 by Robert J. Scaringe, the company is headquartered in Plymouth, Michigan, with additional facilities across multiple locations, including California, Illinois, the United Kingdom, and Canada. Rivian's primary offerings include the R1T, a five-passenger electric pickup truck, and the R1S, a seven-passenger electric sport utility vehicle. The company aims to advance sustainable mobility by creating innovative electric vehicles that redefine traditional automotive economics while providing a comfortable and eco-friendly driving experience.

Delfi Diagnostics

Series A in 2021
Delfi Diagnostics, Inc. is a biotechnology company based in Baltimore, Maryland, that focuses on the early detection of cancer through non-invasive blood tests. Founded in 2018, the company utilizes advanced technologies such as artificial intelligence and genome sequencing to identify unique patterns of DNA fragmentation in patients' blood. By leveraging machine learning, Delfi develops innovative testing systems aimed at recognizing cancer-associated cell-free DNA fragments, thereby enabling healthcare professionals to detect cancer at its most treatable stage. This approach facilitates timely and effective treatment options, ultimately aiming to improve patient outcomes and recovery speed.

Affinivax

Series C in 2021
Affinivax, Inc. is a biotechnology company based in Lexington, Massachusetts, that specializes in developing vaccines using its innovative Multiple Antigen Presenting System (MAPS) technology. This approach allows for the combination of protective polysaccharides and proteins in a single vaccine, aiming to enhance the immune response against various infectious diseases. Affinivax focuses on a range of pathogens, including Streptococcus pneumoniae, which poses significant health risks to both children and adults. The company seeks to create vaccines that provide broader disease coverage and address infectious diseases lacking effective immunization strategies. Founded in 2014, Affinivax benefits from insights provided by leading experts in infectious diseases and vaccines, and it has secured support from the Bill & Melinda Gates Foundation, along with exclusive licensing rights from Boston Children’s Hospital for its MAPS technology.

Color

Series D in 2021
Color is a population health technology company founded in 2014 and based in Burlingame, California. It focuses on providing technology and infrastructure for large-scale health initiatives, making advanced healthcare services accessible and cost-effective. Color's Population Genomics Platform offers modular and comprehensive solutions designed to help health systems, employers, and research institutions develop and implement effective population health programs. The company combines innovative technology with specialized laboratory infrastructure and clinical services, facilitating various aspects of health programs, including strategy, participant engagement, genetic testing, data management, and clinical reporting. Color’s partnerships with organizations such as the National Institutes of Health and Verily enhance its capabilities, enabling it to deliver precision health programs that address the challenges of traditional healthcare access and costs.

FogPharma

Venture Round in 2021
FogPharma is a healthcare company founded in 2015 and headquartered in Gloucester, Massachusetts. The firm is dedicated to the pharmaceutical sector, with a primary focus on developing innovative treatments for cancer. It operates with the support of a diverse group of private and institutional investors, fostering collaboration among its founders, employees, and advisors. FogPharma aims to create a new class of medicines designed to extend and enhance the lives of cancer patients. The company's commitment to its mission drives its efforts to pioneer effective solutions in cancer treatment.

Tempus

Series G in 2020
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.

Genesis Therapeutic

Series A in 2020
Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in a molecular generation and property prediction. The company was founded in 2019 and based in South San Francisco, California.

Flexe

Series C in 2020
FLEXE, Inc. operates a cloud-based warehousing services marketplace that connects organizations needing additional storage and fulfillment capacity with those that have surplus space. Founded in 2013 and based in Seattle, Washington, the company provides a platform that facilitates efficient warehouse sourcing and setup, streamlining material handling operations for clients including retailers, wholesalers, manufacturers, and logistics firms. By addressing inventory overflow and fulfillment challenges, FLEXE enhances the logistics industry and enables businesses to achieve greater structural flexibility in their operations. The company aims to optimize the global delivery of goods and improve access to affordable warehousing solutions, ultimately helping enterprises strengthen their distribution networks and maximize revenue potential.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.